1 Munich Cancer Registry Baseline statistics Selection Matrix Homepage Deutsch Munich Cancer Registry at Munich Cancer Center Marchioninistr. 15 Munich, Germany Cancer statistics: Survival Year of diagnosis Patients 1,265 Diseases 1,268 Cases evaluated 621 Creation date 5/13/215 Export date 12//214 Population 4.64 m BERLIN GERMANY BAVARIA MUNICH E.pdf
2 Survival Page 2 of 7 Period of diagnosis % Relative survival N= Period of diagnosis n= % n= % 27+ n= % SEER n=7, Years Figure 1a. Relative survival of patients with mesothelioma by period of diagnosis. Included in the evaluation are 621 cases diagnosed between 1988 and 213. The survival results of the SEER program (Surveillance, Epidemiology, and End Results) of the American National Cancer Institute (NCI) are summarized as the period of diagnosis from 1998 to 211, and are represented by gray diamonds in order to facilitate comparisons between MCR and SEER. The presented survival curves are derived from clinical records with valid follow-up informations, which means that death certificate cases (DCO) cases are omitted from the analysis. With this one restriction, the MCR has provided populationbased statistics since 1988, collecting data on all cancer cases in the region of southern Bavaria. Historical data of previous time periods can be heavily selected, therefore, univariate survival comparisons of the presented time periods must be carefully considered. Nonetheless, all calculable survival curves are depicted to facilitate the comparison of long time follow-up analyses of relative survival between particular cancers. Period of diagnosis n=82 n=354 n=185 Years obs. % rel. % obs. % rel. % obs. % rel. % Table 1b. Observed (obs.) and relative (rel.) survival of patients with mesothelioma by period of diagnosis for period (N=621).
3 Survival Page 3 of 7 Gender % Survival N=621 1 Gender 8 Male n= 8.5% Female n= % Observed Expected Relative Years Figure 2a. Survival of patients with mesothelioma by gender. Included in the evaluation are 621 cases diagnosed between 1988 and 213. Gender Male Female n= n=121 Years obs. % rel. % obs. % rel. % Table 2b. Observed (obs.) and relative (rel.) survival of patients with mesothelioma by gender for period (N=621).
4 Survival Page 4 of 7 Age category % Relative survival N= Age category -59 yrs n= % -69 yrs n=2 37.% + yrs n=2 4.3% Years Figure 3a. Relative survival of patients with mesothelioma by age category. Included in the evaluation are 621 cases diagnosed between 1988 and 213. Age category -59 yrs -69 yrs + yrs n=141 n=2 n=2 Years obs. % rel. % obs. % rel. % obs. % rel. % Table 3b. Observed (obs.) and relative (rel.) survival of patients with mesothelioma by age category for period (N=621).
5 Survival Page 5 of 7 Post-progression survival % Observed survival N= Type of progression All types n=245 1.% Locoregional progress n= % Months Figure 5a. Observed post-progression survival of 245 patients with mesothelioma diagnosed between 1988 and 213 (incl. M1). These 245 patients with documented progression events during their course of disease represent 39.5% of the totally 621 evaluated cases. Patients with cancer relapse documented via death certificates only were excluded (n=236, 38.%). Multiple progression types on different sites are included in the evaluation even when not occuring synchronously. Medical record documentation often lacks the linguistic severity to distinguish between local relapse, regional lymph node metastasis and distant spread in solid cancers. Frequently, the statement not specified is the only information in registries regarding relapse of the disease. The category All types denotes all cases who suffered from at least one relapse during the course of disease (incl. primary M1-status). Although, the real number of relapsed patients is likely to be much higher. The accumulated percentage of patients with local relapse or distant metastasis exceeds the 1% value because patients are potientially considered in more than one subgroup. Type of progression All types Locoregional progress n=245 n=39 Months % % Table 5b. Observed post-progression survival of patients with mesothelioma for period (N=245).
6 Survival Page 6 of 7 Shortcuts MCR Munich Cancer Registry, Germany (Tumorregister München) NCI National Cancer Institute, USA SEER Surveillance, Epidemiology, and End Results, USA UICC Union for International Cancer Control, Geneva DCO Death certificate only. The death certificate provides the only notification to the registry. NA Not available NOS Not otherwise specified OS Observed/overall survival (Kaplan-Meier estimate) RS Relative survival, compared to the general population, ratio of observed to expected survival (Ederer II method), reflecting excess mortality among cancer patients AS Assembled survival chart (observed, expected, relative) PPS Post-progression survival, survival since first relapse (Kaplan-Meier estimate) Date of entry: Date of first locoregional recurrence, distant metastasis, unspecified progression Event: Death of all causes CS Conditional survival, survival probability under the condition of surviving a given period of time Recommended Citation Munich Cancer Registry. Survival [Internet]. 215 [updated 215 May 13; cited 215 Jul 1]. Available from: E.pdf Copyright The content of the public web site provided by the Munich Cancer Registry is available worldwide and free of charge. All documents are free to download, utilize, copy, print-out and distribute, providing that the MCR is referenced. Disclaimer The Munich Cancer Registry reserves the right to not be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.
7 Survival Page 7 of 7 Fig./Tbl. Index of figures and tables Page 1a Relative survival by period of diagnosis (chart) 2 1b Survival by period of diagnosis (table) 2 2a Survival by gender (chart) 3 2b Survival by gender (table) 3 3a Relative survival by age category (chart) 4 3b Survival by age category (table) 4 5a Observed post-progression survival (chart) 5 5b Observed post-progression survival (table) 5
Disease Markers Volume 2015, Article ID 282145, 5 pages http://dx.doi.org/10.1155/2015/282145 Research Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma Emanuela Taioli,
Suggested Grade Levels: 9 and up Likelihood of Cancer Possible Subject Area(s): Social Studies, Health, and Science Math Skills: reading and interpreting pie charts; calculating and understanding percentages
Cancer in Western Australia: Incidence and mortality 2003 and Mesothelioma 1960-2003 A report of the Western Australian Cancer Registry Health Data Collections, Information Collection and Management Department
Trends in Asthma Morbidity and Mortality American Lung Association Epidemiology and Statistics Unit Research and Health Education Division September 2012 Table of Contents Asthma Mortality, 1999-2009 Asthma
Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat Issued: September
Welcome to the International Classification of Diseases, Ninth Revision (ICD-9) Diagnosis Code Requirements Part I course. Note: This module applies to Responsible Reporting Entities (RREs) that will be
MedPage Tools Guide to Biostatistics Study Designs Here is a compilation of important epidemiologic and common biostatistical terms used in medical research. You can use it as a reference guide when reading
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GENERAL CONSIDERATIONS FOR CLINICAL TRIALS E8 Current
Preparing an estimate of the national pattern of exposure to asbestos in cases of malignant mesothelioma JULY 2008 Copyright Notice Commonwealth of Australia 2008 ISBN 978 0 642 32792 5 This work is copyright.
MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 28 MORTALITY 1997 TO 27 August 212 Safe Work Australia Mesothelioma in Australia Incidence 1982 to 28 Deaths 1997 to 27 August 212 Acknowledgement Data on the
Health Data Analysis Toolkit American Health Information Management Association 2011 Table of Contents Foreword...3 Authors and Acknowledgments...3 Introduction...4 Data Dictionary...5 Study Design and
The Quigley Asbestos PI Trust (the Trust ) was established pursuant to the Quigley Company, Inc. Fifth Amended and Restated Plan of Reorganization under Chapter 11 of the United States Bankruptcy Code,
ENVIRONMENTAL RESEARCH 75, 34 40 (1997) ARTICLE NO. ER973770 Mesothelioma Incidence and Community Asbestos Exposure Michael Berry Consumer and Environmental Health Services, New Jersey Department of Health
australian mesothelioma registry 2nd Annual Report Mesothelioma in Australia 2012 The Australian Mesothelioma Registry is funded by Safe Work Australia and Comcare. Creative Commons ISBN 978-1-74361-136-4
Table of Contents WOMEN S HEALTH INITIATIVE PUBLICATIONS AND PRESENTATIONS (P&P) POLICY Overview and Definition of Terms...1 P&P Review Process and Guidelines...2 Manuscript Proposals Final Manuscripts
General Remarks This template of a data extraction form is intended to help you to start developing your own data extraction form, it certainly has to be adapted to your specific question. Delete unnecessary
Lung disease in Australia Leanne M Poulos Patricia K Correll Brett G Toelle Helen K Reddel Guy B Marks Woolcock Institute of Medical Research, University of Sydney, NSW Prepared for Lung Foundation Australia
A Review of the Definition for Multiple Primary Cancers in the United States Workshop Proceedings From December 4-6, 2002, in Princeton, New Jersey Editor: Holly L. Howe, Ph.D. Executive Director NAACCR
December 7, 2006 Where Are Mesothelioma Claims Heading? Paul Hinton, Ron Miller, Faten Sabry, and Fred Dunbar NERA Economic Consulting i Table of Contents I. Introduction...1 II. III. Background...1 Evidence
GAO United States Government Accountability Office Report to the Chairman, Committee on the Judiciary, House of Representatives September 2011 ASBESTOS INJURY COMPENSATION The Role and Administration of
Core Set of Health Care Quality Measures for Medicaid Health Home Programs Technical Specifications and Resource Manual for Federal Fiscal Year 2013 Reporting March 2014 Center for Medicaid and CHIP Services
ORIGINAL CONTRIBUTION JAMA-EXPRESS Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women Principal Results From the Women s Health Initiative Randomized Controlled Trial Writing
Summary of Investigation into the Occurrence of Cancer Census Tract 2104 Zip Code 77009, Houston Harris County, Texas 1998 2007 May 11, 2010 Background: Concern about a possible excess of cancer prompted
Work-Related Lung Disease Surveillance Report 2002 Division of Respiratory Disease Studies National Institute for Occupational Safety and Health U.S. Department of Health and Human Services Public Health
U.S. Department of Justice Office of Justice Programs Bureau of Justice Statistics Special Report March 1997, NCJ-160092 Lifetime Likelihood of Going to State or Federal Prison By Thomas P. Bonczar and
Mortality Following Inpatient Addictions Treatment Role of Tobacco Use in a Community Based Cohort Richard D. Hurt, MD; Kenneth P. Offord, MS; Ivana T. Croghan, PhD; Leigh Gomez-Dahl; Thomas E. Kottke,